Clinical trial Recruiting at 1 site Observational Ages 18 to 80

Brain and spinal cord MRI changes in adults with cerebral palsy

Official title: Evaluation of Brain Changes in Cerebral Palsy Patients

Run by Columbia University · NCT07433647 · Data updated 2026-11-12

We will look at past and new brain and spinal cord MRIs to see if adults with cerebral palsy develop brain or spinal cord atrophy over time.

Quick facts

Study typeObservational
Ages18 Years to 80 Years
SexAll
Enrollment30 (estimated)
SponsorColumbia University
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedJune 20, 2023
Main results expectedJuly 1, 2028
Study endsJuly 1, 2029
Registry record updatedMay 13, 2026
Trial IDNCT07433647 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–80 with a diagnosis of cerebral palsy who are enrolled in the Cerebral Palsy Research Network and have multiple brain or spinal MRIs spaced at least 24 months apart and no other degenerative neurologic conditions.

Probably not a fit

People with only a single MRI, known degenerative genetic disorders, multiple seizures, significant prior head trauma, metallic head implants, or under age 18 are unlikely to benefit from participating.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center, observational project will collect longitudinal clinical MR images from adults with cerebral palsy, using the Cerebral Palsy Research Network to assemble scans from across the United States. Investigators will quantify brain volume, cortical thickness, and spinal cord cross-sectional area on multiple MRIs at least 24 months apart and correlate imaging change with measures of function over time. The analysis focuses on adults aged 18–80 with no other known degenerative neurologic disease, excluding cases with significant head trauma, multiple seizures, or metallic head implants. Retrospective clinical images and prospective scans sent to Columbia will be centrally analyzed for patterns of atrophy or structural change.

Why it matters

Potential benefit: If changes are found, the findings could help explain age-related functional decline in adults with cerebral palsy and guide monitoring or interventions.

How similar studies have gone: Cross-sectional MRI studies have documented white and gray matter abnormalities in cerebral palsy, but longitudinal evidence for progressive atrophy in adults with CP is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Have multiple MRI scans of brain and/or spinal cord spaced at least 24 months apart
* Between 18-80 years of age with at least one MRI scan after the age of 18
* No known central or peripheral neurological disease or injury other than cerebral palsy causing brain degeneration
* Inclusion in CPRN registry
* diagnosis of Cerebral Palsy
* \>18 years of age
* Have received at least one past brain MRI scan as part of standard care (patients who have two or more brain MRI scans can be included in the retrospective arm only)

Exclusion Criteria:

* History of more than one seizure in lifetime
* History of known degenerative genetic disorder
* History of brain tumor, abscess, or multiple sclerosis
* History of moderate or severe head trauma
* History of metal implants in head

Where it's running

  • Weinberg Family Cerebral Palsy Center, Columbia University
    New York, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.